Related Experiment Video
Updated: Aug 8, 2026
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
[Ebastine vs terfenadine in allergic rhinitis]
L Terán Ortíz1, G Flores Sandoval, M Orea Solano
1Laboratorio de inmunologia e histocompatibilidad INER, SS.
Revista Alergia : Organo Oficial De La Sociedad Mexicana De Alergia E Inmunlogia
|July 1, 1993
Summary
Ebastine, a second-generation antihistamine, demonstrated superior efficacy in managing allergic rhinitis symptoms compared to terfenadine. This study highlights ebastine
Area of Science:
- Allergy and Immunology
- Pharmacology
- Clinical Medicine
Background:
- Allergic rhinitis significantly impacts quality of life.
- Second-generation antihistamines offer improved safety profiles over older agents.
- Evaluating novel antihistamines for effective rhinitis management is crucial.
Purpose of the Study:
- To compare the efficacy of ebastine versus terfenadine in treating allergic rhinitis.
- To assess symptom control in pediatric and adolescent patients.
- To evaluate the safety and tolerability of ebastine.
Main Methods:
- Prospective, comparative, randomized study.
- 40 patients with allergic rhinitis were treated with ebastine or terfenadine.
- Dosage of ebastine varied by age: 10 mg for 5-10 year olds, 20 mg for 11-15 year olds.
Main Results:
- Ebastine showed significantly greater efficacy in controlling rhinorrhea, nasal obstruction, sneezing, and itching from day seven (p < 0.05).
- Overall efficacy rates for ebastine (10/20 mg) were superior to terfenadine (p < 0.05).
- Ebastine exhibited good tolerability, with minor side effects (sleepiness, headache, nausea) in 1.5% of patients.
Conclusions:
- Ebastine is a more effective second-generation antihistamine for allergic rhinitis symptom control than terfenadine.
- Ebastine offers a favorable safety profile for pediatric and adolescent populations.
- The study supports ebastine as a valuable therapeutic option for allergic rhinitis.
Related Concept Videos
01:28Adrenergic Agonists: Mixed-Action Agents
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:15Upper Respiratory Drugs: First and Second-Generation Antihistamines
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...